Cardiovascular risk in juvenile idiopathic arthritis
Elizabeth J Coulson1, Wan-Fai Ng, Iain Goff
1Rheumatology Department, Freeman Hospital, High Heaton, Newcastle upon Tyne NE7 7DN, UK. elizabeth.coulson@nuth.nhs.uk
Insights
Children with Juvenile Idiopathic Arthritis (JIA) may face significant long-term cardiovascular risks. Further research is needed to establish clear cardiovascular risk assessment guidelines for JIA patients.
Area of Science:
- Pediatric Rheumatology
- Cardiovascular Health
- Inflammatory Diseases
Background:
- Juvenile Idiopathic Arthritis (JIA) is the most common chronic inflammatory arthritis in children.
- Over one-third of JIA patients experience persistent disease into adulthood.
- Adults with Rheumatoid Arthritis (RA) show increased cardiovascular mortality and morbidity.
Purpose of the Study:
- To examine the current evidence regarding cardiovascular risk in individuals with JIA.
- To highlight the uncertainty surrounding long-term cardiovascular outcomes in JIA.
- To address the lack of specific cardiovascular risk assessment guidance for JIA.
Main Methods:
- Review of existing literature on JIA and cardiovascular health.
- Comparison of cardiovascular risk factors and outcomes in JIA versus adult-onset inflammatory arthritis.
- Analysis of the role of systemic inflammation in atherosclerosis acceleration.
Main Results:
- Cardiovascular risk in JIA is not well-defined, unlike in RA.
- Potential for longer disease duration in JIA may increase cardiovascular risk.
- Inflammation's role in atherosclerosis acceleration is a concern for JIA patients.
Conclusions:
- There is a need for dedicated cardiovascular risk assessment strategies for JIA.
- Understanding JIA's long-term cardiovascular impact is crucial for patient management.
- JIA may pose a greater cardiovascular risk than adult-onset inflammatory arthritides due to disease chronicity.
Abstract:
JIA is the most common chronic inflammatory arthritis in children and young people. More than one-third of individuals have persistent active disease into adulthood. In RA, there has been considerable interest in long-term cardiovascular outcomes. Increased cardiovascular mortality and morbidity have been observed and consensus guidelines recommend annual cardiovascular risk assessment for adults with RA. The increased risk is attributed to a higher prevalence of traditional cardiovascular risk factors and the role of systemic inflammation in the acceleration of atherosclerosis. The long-term risk of cardiovascular disease for individuals with JIA remains uncertain and guidance on risk assessment is not currently available. Given the potential for longer disease duration, it is possible that cardiovascular risk in this group surpasses that observed in adult-onset inflammatory arthritides. In this article, we consider the evidence for cardiovascular risk in JIA.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis I: Introduction
Pericarditis I: Introduction
